
Europe Blood Irradiation Market
No. of Pages: 109 | Report Code: BMIRE00027192 | Category: Life Sciences
No. of Pages: 109 | Report Code: BMIRE00027192 | Category: Life Sciences
The blood irradiation market in Europe is expected to grow from US$ 26.90 million in 2022 to US$ 40.24 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028.
Rise in Healthcare Expenditure and Government Initiatives Bolsters Europe Blood Irradiation Market
The therapeutic landscape of communicable and noncommunicable diseases is evolving with time and technology, increasing healthcare expenditure, and surging awareness in a large population. X-ray and gamma irradiators are widely used for blood irradiation to ensure patient safety and prevent further complications. Blood irradiation helps manage hematological malignancies and prevents transfusion-associated graft-versus-host (TGVH) disease. The FDA has approved the use of blood irradiators, along with implementing tighter security measures to reduce the risk of unauthorized use of radioactive materials. The Serious Hazards of Blood Transfusion (SHOT) scheme of the UK government supports patient safety by analyzing anonymized information gathered on adverse events and reactions reported by from healthcare organizations involved in the blood and blood components transfusion after the transfusion procedures. Moreover, European Blood Alliance (EBA), Voluntary Blood Donation in Rhodope, and various other government and nongovernment organizations/projects from European countries are creating awareness among people regarding blood donation to fulfill the increasing demand for blood. Thus, such government and nongovernment initiatives for encouraging blood donation are driving the growth of the blood irradiation market.
Market Overview
Europe is the second-largest market for blood irradiation, and the market growth in this region is attributed to factors such as the rising prevalence of cancer, cardiac stroke, diabetes, and various other noncommunicable chronic diseases. In addition, growing funding for research & development activities is likely to provide opportunities for the market players in the coming years. Moreover, the pharmaceutical industry in Germany holds the fourth largest position with small and mid-sized companies. The country is likely to remain one of the most attractive destinations for the Europe healthcare industry over the coming years in terms of treatment. The industry's growth is driven by various factors such as increasing investment for research and development, and advanced healthcare facilities like hospitals, blood banks, and clinics. The blood irradiation market in Germany is primarily driven by countries aging population, socio-political environment and high per capita healthcare expenditure.
Strategic insights for the Europe Blood Irradiation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Blood Irradiation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Europe Blood Irradiation Strategic Insights
Europe Blood Irradiation Report Scope
Report Attribute
Details
Market size in 2022
US$ 26.90 Million
Market Size by 2028
US$ 40.24 Million
Global CAGR (2022 - 2028)
6.9%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type
By Indication
By End User
Regions and Countries Covered
Europe
Market leaders and key company profiles
Europe Blood Irradiation Regional Insights
Europe Blood Irradiation Market Segmentation
The Europe blood irradiation market is segmented into type , indication, end user, and country.
Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the region.
The Europe Blood Irradiation Market is valued at US$ 26.90 Million in 2022, it is projected to reach US$ 40.24 Million by 2028.
As per our report Europe Blood Irradiation Market, the market size is valued at US$ 26.90 Million in 2022, projecting it to reach US$ 40.24 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Blood Irradiation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Blood Irradiation Market report:
The Europe Blood Irradiation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Blood Irradiation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Blood Irradiation Market value chain can benefit from the information contained in a comprehensive market report.